Kidney involvement in antiphospholipid syndrome – current diagnostic and management problems

Maria Majdan

doi:10.5114/reum.2017.71626

5/2017 vol. 55

Get citation

EDITORIAL ARTICLE

Kidney involvement in antiphospholipid syndrome – current diagnostic and management problems

Maria Majdan

More details

Hide details

Online publication date: 2017-10-28

Reumatologia 2017;55(5):213-214

DOI: https://doi.org/10.5114/reum.2017.71626

Article (PDF)

References (15)

REFERENCES (15)

Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.

Google Scholar

Gerosa M, Rovelli F. Non-classification criteria w Antiphospholid antibody syndrome – from bench to bedside. In: Antiphospholid antibody syndrome – from bench to bedside, Meroni PL (ed.). Springer, Heidelberg, New York, Dordrecht, London 2015: 61-74.

Google Scholar

Abreu MM, Danowski A, Wahl DG, et al. The relevance of “non-criteria” clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. Autoimmun Rev 2015; 14: 401-414.

Google Scholar

Gracia-Tello B, Isenberg D. Kidney disease in primary antiphospholipid antibody syndrome. Rheumatology 2017; 56: 1069-1080.

Google Scholar

Bienaime F, Legendre Ch, Terzi F, et al. Antiphospholipid syndrome and kidney disease. Kidney Int 2017; 91: 34-44.

Google Scholar

Sciascia S, Baldovino S, Schreiber K, et al. Antiphospholipid syndrome and the Kidney. Semin Nephrol 2015; 35: 478-486.

Google Scholar

Tektonidou MG. Identification and treatment of APS renal involvement. Lupus 2014; 23: 1276-1278.

Google Scholar

Alchi B, Griffiths M, Jayne D. What nephrologists need to know about antiphospholipid syndrome. Nephrol Dial Transplant 2010; 25: 3147-3154.

Google Scholar

Majdan M. The kidney and antiphospholipid syndrome. Pol Arch Med Wewn 2007; 117 (suppl 1): 55-58.

Google Scholar

10.

Majdan M. Antiphospholipid syndrome and kidney diseases. Pol Merkur Lek 2010; 28: 341-344.

Google Scholar

11.

Ünlu O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol 2016; 3: 75-84.

Google Scholar

12.

Gerhardsson J, Sundelin B, Zickert A, et al. Histological antiphospholipid – associated nephropathy versus lupus nephritis in patients with systemic lupus erythematosus: an observational cross-sectional study with longitudinal follow-up. Arthritis Res Ther 2015; 17: 109.

Google Scholar

13.

Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 2015; 11: 586-596.

Google Scholar

14.

Choi JY, Jung JH, Sung S, et al. Living donor renal transplantation with antiphospholipid syndrome. Medicine 2016; 95: 46-50.

Google Scholar

15.

Geethakumari PR, Mille P, Gulati, Nagalla S. Complement inhibition with eculizumab for thrombotic microangiopathy rescues a living-donor kidney transplant in a patients with antiphospholipid antibody syndrome. Transfus Appher Sci 2017; 56: 400-403.

Google Scholar

Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Submit your paper

eISSN:	2084-9834
ISSN:	0034-6233